Results 11 to 20 of about 295,979 (212)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence

Lupus Science and Medicine, 2021
Background Use of hydroxychloroquine (HCQ) is common in patients with lupus erythematosus. Long-term use (ie, ≥5 years) and high-dose HCQ (ie, >5 mg/kg/day) are both risk factors for developing HCQ retinopathy.
Ronald F van Vollenhoven, Alain Cornet, Jeanette Andersen, Zgjim Osmani, Thijs J Schrama, Wendy Zacouris-Verweij, Susan Frankel, Irene E M Bultink   +7 more
doaj   +1 more source

Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

Reumatismo, 2022
Not ...
F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti   +5 more
doaj   +1 more source

Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study

Biomolecules, 2022
We longitudinally followed a single-center cohort of anti-phospholipid (aPL) positive healthy subjects to evaluate the evolution to systemic autoimmune diseases (sAD) and to describe clinical and serological associated features.
Fulvia Ceccarelli, Francesco Natalucci, Giulio Olivieri, Carmelo Pirone, Licia Picciariello, Valeria Orefice, Simona Truglia, Francesca Romana Spinelli, Cristiano Alessandri, Antonio Chistolini, Fabrizio Conti   +10 more
doaj   +1 more source

Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus [PDF]

Rheumatology, 2017
n ...
GOVONI, Marcello, BORTOLUZZI, Alessandra
openaire   +2 more sources

Early Discoid Lupus Erythematosus Protects Against Renal Disease In Patients With Systemic Lupus Erythematosus: Longitudinal Data From A Large Latin American Cohort [PDF]

, 2017
The objective of this study was to examine whether early discoid lupus erythematosus (DLE) would be a protective factor for further lupus nephritis in patients with systemic lupus erythematosus (SLE).
V.; Alvarellos, E. M.; Chacon-Diaz, M. J.; Sato, A.; Caeiro, L. T. L.; Neira, R.; Drenkard, C., E. I.; Soriano, G. J.; Aspey, D.; Saurit, F.; Haye Salinas, M. H.; Acevedo-Vasquez, O.; Iglesias-Gamarra, L. D.; Bao, G.; Cardiel, Pons-Estel, E. R.; Costallat, A.; Reyes-Llerena, G.; Pons-Estel, B. A.; Wojdyla   +19 more
core   +6 more sources

Autoantibodies against complement C1q in systemic lupus erythemathosus [PDF]

, 2008
Complement and C1q, the first component of the classical pathway of activation of the complement system, are considered to be involved in the pathogenesis of systemic lupus erythematosus (SLE), a systemic autoimmune disease.
Bigler, Cornelia
core   +1 more source

Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children [PDF]

, 2008
: To evaluate disease characteristics of childhood onset SLE in Latin America and to compare this information with an adult population in the same cohort of GLADEL.
D Wojdyla, MH Cardiel, Romero Grisales, Hugo de Jesús, Ramírez Gómez, Luis Alberto, Cardiel Ríos, Mario Humberto, O Uribe Uribe, H Grisales Romero, O Osio Uribe, BA Pons-Estel, Osio Uribe, Oscar, Pons Estel, Bernardo, LA Ramírez Gómez, Wojdyla, Daniel, Uribe Uribe, Oscar   +13 more
core   +1 more source

Regula monachorum ex Epistolis Hieronymi excerpta [PDF]

Keine Titelseite; Textbeginn Bl. 1a: Jncipit aureola feliciter ...Impressum gemäss ISTCThe Aureola is the work elsewhere attributed to Lupus de Oliveto (or Olmeto) with title Regula monachorum ex Epistolis Hieronymi excerpta (B.
Lupus
core   +3 more sources

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

RMD Open, 2019
Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses.
David Jayne, Rachel B Jones, Vítor Teixeira, Aladdin J Mohammad, Rona Smith   +4 more
doaj   +1 more source

A Toll for lupus [PDF]

, 2005
Toll-like receptor (TLR)-9 recognizes CpG motifs in microbial DNA. TLR9 signalling stimulates innate antimicrobial immunity and modulates adaptive immune responses including autoimmunity against chromatin, e.g., in systemic lupus erythematosus (SLE ...
Anders, Hans-Joachim, H-J Anders
core   +1 more source